⚠ Evidence warning: Clinical trials or other evidence do not support the claim that Lion's Mane heals the gut lining, rebalances gut bacteria, helps inflammatory bowel disease, functional dyspepsia and H. pylori gastritis in people, and acts on gut nerves to improve mood and thinking; the evidence is animal and cell studies plus one retrospective study of a multi-ingredient product in ulcerative colitis. This page keeps it as a report of what people, websites or other media say.

Lion's Mane for Gut Health

Gut Health — scientific infographic poster

Long before the modern NGF research made Lion's Mane famous as a brain mushroom, Chinese and Japanese traditional medicine used Hericium erinaceus as a digestive remedy for chronic gastritis, peptic ulcer disease, and what we now call functional dyspepsia. A 2013 rat study by Wong and colleagues, using ulcers caused by ethanol, found a significant reduction in ulcer area with a water (aqueous) extract of Lion's Mane given beforehand. The beta-glucan polysaccharides in the fungal cell wall signal through the Dectin-1 receptor on intestinal macrophages and dendritic cells, modulating mucosal immunity in a manner consistent with the historical "stomach tonic" reputation. The mushroom also acts as a prebiotic, supporting beneficial gut bacteria and producing the short-chain fatty acids that maintain colonic epithelial integrity. In inflammatory bowel disease the colitis findings come from animal studies, and the human data are one 2024 retrospective study of a multi-ingredient product based on Lion's Mane in ulcerative colitis. The most interesting aspect is the gut-brain axis bridge: the same hericenones that act peripherally on enteric neurons connect Lion's Mane's digestive effects to its cognitive and mood effects, since vagal afferent signaling from gut to brain is a major and increasingly appreciated regulator of central neuroinflammation and mood.


Table of Contents

  1. Traditional Chinese and Japanese Digestive Use
  2. The Wong 2013 Ethanol-Induced Gastric Ulcer Study
  3. Beta-Glucan and Dectin-1 Mucosal Immunity
  4. Microbiome Modulation and Prebiotic Effects
  5. Gut Barrier Integrity and Tight Junctions
  6. Pilot Data in Inflammatory Bowel Disease
  7. Helicobacter pylori and Gastritis
  8. Functional Dyspepsia and Gastroesophageal Reflux Disease
  9. The Gut-Brain Axis Bridge to Cognitive and Mood Effects
  10. Preparation Choice for Gut Applications
  11. Dose and Pairing with Other Gut Interventions
  12. Cautions
  13. Key Research Papers
  14. Connections
  15. Featured Videos

Traditional Chinese and Japanese Digestive Use

Classical Chinese herbal texts (Compendium of Materia Medica, Bencao Gangmu, 16th century, and earlier works) describe hou tou gu (Lion's Mane, literally "monkey head mushroom") with three main indications:

  1. Brain tonic for memory and clarity (the cognitive use covered on the Cognitive Function page)
  2. Digestive remedy for chronic stomach complaints — recommended for what classical Chinese medicine described as "stomach yin deficiency" with symptoms of chronic indigestion, dull epigastric pain, reduced appetite, and what would now be recognized as functional dyspepsia, chronic gastritis, and possibly peptic ulcer disease
  3. Tonic for "five organ" health and longevity

In Japanese traditional medicine (kampo and the broader Buddhist-monastic medical tradition), Lion's Mane (yamabushitake) was used similarly for digestive complaints alongside its cognitive applications. The traditional preparation was typically a long-simmered soup or a hot-water extract drunk as a tea, which extracts the polysaccharides and beta-glucans (the most therapeutically relevant gut-active fraction) while degrading the more delicate aromatic hericenones somewhat. This preparation method matches the modern hot-water-extracted polysaccharide preparations sold for gut indications.

The traditional use predated by centuries the modern Helicobacter pylori discovery (Warren and Marshall 1982), the modern understanding of mucosal immunity, the development of proton pump inhibitors, and the recognition of the gut microbiome's role in health. The empirical observation that Lion's Mane helped chronic stomach complaints was based on practitioner experience and outcome over many generations of use, and the modern molecular mechanism (beta-glucan immune modulation, gastric mucosal protection, prebiotic microbiome effect) has provided several plausible biological explanations for why the traditional use produced the results that drove its longevity.

Back to Table of Contents

The Wong 2013 Ethanol-Induced Gastric Ulcer Study

A modern experimental study of Lion's Mane stomach protection is Wong JY and colleagues (2013), "Gastroprotective Effects of Lion's Mane Mushroom Hericium erinaceus Extract against Ethanol-Induced Ulcer in Rats." The ethanol-induced gastric ulcer rat model is a standard preclinical assay for gastric mucosal protective agents — ethanol directly damages gastric epithelium and produces reproducible ulcers that can be quantified by area measurement.

The Wong group pretreated Sprague Dawley rats with an aqueous extract of Lion's Mane before the ethanol challenge, then measured ulcer area, stomach-wall mucus, the damage seen by eye and under the microscope, antioxidant enzyme levels and malondialdehyde (MDA, a marker of fat damage by oxidation). Results showed:

The mechanism appears to involve preservation of the gastric mucus barrier (mediated by mucin glycoproteins secreted by gastric foveolar cells), reduction of acute inflammatory response, and possibly direct stimulation of mucosal repair. A later rat study of Lion's Mane polysaccharide (Wang XY 2018) found that pre-treatment reduced ethanol-induced stomach-lining lesions and ulcers caused by tying off the stomach outlet (pylorus ligation), lowered tumor necrosis factor-alpha and interleukin-1-beta in serum, and increased the defensive factors nitric oxide, prostaglandin E2 and epidermal growth factor in stomach tissue. Prostaglandin E2 is the principal cytoprotective signal for the gastric mucosa (the same mechanism that nonsteroidal anti-inflammatory drugs (NSAIDs) disrupt and that proton pump inhibitors indirectly support).

These results come from rats. People with stress-related gastritis, NSAID-induced gastric irritation, or chronic Helicobacter pylori-associated gastritis are the groups this research points to, but randomized controlled trials in humans for these specific indications have not yet been conducted at adequate scale.

Back to Table of Contents

Beta-Glucan and Dectin-1 Mucosal Immunity

The fungal cell wall is rich in beta-(1,3)/(1,6)-glucans — long branched polysaccharides that are structurally distinct from the (1,4)-glucans of plant starch and from the (1,3)-glucans of bacterial origin. Beta-(1,3)/(1,6)-glucans are recognized by the Dectin-1 receptor (CLEC7A), a C-type lectin pattern recognition receptor expressed on the surface of macrophages, dendritic cells, monocytes, and neutrophils, with particularly dense expression on intestinal macrophages and dendritic cells in the gut lamina propria.

Dectin-1 binding by fungal beta-glucan produces several downstream effects:

The net effect of beta-glucan consumption in the gut is generally immunomodulatory rather than purely immunostimulatory or immunosuppressive. The same compound that primes macrophages to fight fungal infection also contributes to Th17/Treg balance that maintains tolerance to commensal bacteria and food antigens. This dual nature is why beta-glucan-containing mushrooms (Lion's Mane, Reishi, Turkey Tail, Maitake, Shiitake) feature prominently in traditional medical systems for both immune support during illness and ongoing immune balance during health.

Beta-glucan content is the most useful single quality marker for fungal supplement potency. Genuine fruit-body extracts typically test at 25-40% beta-glucan by weight. Mycelium-on-grain products often test below 10% because the residual grain dilutes the fungal content and grain (1,3)-glucans are different from fungal (1,3)/(1,6)-glucans. Beta-glucan testing is reported on third-party-tested supplement product labels and is a useful comparison metric across brands.

Back to Table of Contents

Microbiome Modulation and Prebiotic Effects

Beyond the direct immune effects, Lion's Mane polysaccharides act as a prebiotic — a substrate that selectively feeds beneficial gut bacteria. The non-digestible polysaccharides resist human digestive enzymes in the small intestine and reach the colon intact, where they are fermented by colonic bacteria to produce short-chain fatty acids (acetate, propionate, butyrate).

Animal studies of Lion's Mane supplementation consistently show:

Butyrate is the most therapeutically interesting short-chain fatty acid. It is the principal energy source for colonocytes (colonic epithelial cells), supports tight junction integrity, has anti-inflammatory effects through histone deacetylase (HDAC) inhibition, and supports Treg differentiation in the colonic lamina propria. Reduced butyrate production is a feature of dysbiosis in inflammatory bowel disease, irritable bowel syndrome, and several metabolic conditions.

Lion's Mane as a prebiotic fits within the broader picture of dietary fiber and resistant starch supporting microbiome health. It is not a replacement for diverse plant fiber (the most robust evidence for microbiome diversity comes from diversity of plant intake), but it is a useful adjunct, particularly for individuals who have used antibiotics, have inflammatory bowel disease, or have other risk factors for dysbiosis. See the Probiotics page for the complementary approach of direct beneficial-bacteria supplementation.

Back to Table of Contents

Gut Barrier Integrity and Tight Junctions

The gut barrier is a remarkable structure: a single layer of columnar epithelial cells separates the entire microbial mass of the colon (approximately 38 trillion bacteria) from the sterile interior of the body. The integrity of this single-cell-layer barrier depends on tight junction proteins (claudins, occludin, ZO-1) that seal the spaces between adjacent epithelial cells, on the protective mucin layer (Muc2 in the colon, Muc5AC in the small intestine), and on antimicrobial peptide production by Paneth cells in the small intestinal crypts.

Loss of gut barrier integrity ("intestinal permeability" or, less precisely, "leaky gut") allows translocation of bacterial products (lipopolysaccharide (LPS) from gram-negative bacteria, peptidoglycan from gram-positive bacteria) and food antigens from the gut lumen into the lamina propria and ultimately into systemic circulation. This is thought to contribute to chronic low-grade systemic inflammation, autoimmune disease susceptibility, food sensitivity, and possibly mood and cognitive symptoms via the gut-brain axis.

Lion's Mane supports gut barrier integrity through several mechanisms operating simultaneously:

  1. Direct epithelial protective effect — the stomach-ulcer protection seen in rats (Wong 2013) is proposed to extend to small and large intestinal epithelium under stress
  2. Microbiome modulation — promoting butyrate-producing bacteria, which support tight junction integrity and colonocyte energy supply
  3. Beta-glucan/Dectin-1 signaling — modulating mucosal immune balance to favor tolerance over inflammation
  4. Mucin support — the prebiotic effect supports goblet cell function and mucin production
  5. Reduction of pathogenic bacterial overgrowth — the gut microbiome modulation reduces abundance of pathobionts that disrupt barrier function

For patients with diagnosed conditions involving gut barrier dysfunction (inflammatory bowel disease, celiac disease, possibly some cases of irritable bowel syndrome and food sensitivity), Lion's Mane is used as one part of a broader gut-healing approach; the only human study found for this page in this area is the ulcerative colitis study described below. See the Gut Healing page for the broader framework.

Back to Table of Contents

Pilot Data in Inflammatory Bowel Disease

Lion's Mane has been studied in inflammatory bowel disease (Crohn's disease and ulcerative colitis) mainly in animals, with one human study:

The available evidence is preliminary and does not support Lion's Mane as primary therapy for inflammatory bowel disease. Standard care — 5-ASA agents, immunomodulators, biologics — remains evidence-based first-line therapy, with surgical options for refractory disease. In the one human study, the Lion's Mane-based product was taken alongside 5-ASA medicine, not in place of it; it has not been studied as a replacement for evidence-based inflammatory bowel disease (IBD) therapy.

The people in that study had mild-to-moderate disease. No study has tested Lion's Mane in severe pancolitis or in place of biologic therapy; stopping a biologic in severe disease carries the risk of a disease flare on inadequate therapy.

Back to Table of Contents

Helicobacter pylori and Gastritis

Helicobacter pylori is a gram-negative spiral bacterium that colonizes the gastric mucosa and is the underlying cause of most peptic ulcer disease and a major risk factor for gastric cancer. The Barry Marshall and Robin Warren discovery of H. pylori (1982, Nobel Prize 2005) transformed peptic ulcer management from antacid suppression to antibiotic eradication.

Lion's Mane has shown modest in vitro and animal-model activity against H. pylori: ethanol extracts of the fruiting body inhibited the growth of laboratory strains and clinical isolates in the laboratory (Shang 2013), and in mice an ethanolic extract left a stomach H. pylori load about 1 log lower than in untreated controls (Wang G 2019). The gastric protective effects discussed above may be partly relevant in the context of H. pylori-associated gastritis. However, the evidence does not establish Lion's Mane as an H. pylori eradication therapy. The 2024 American College of Gastroenterology (ACG) guideline states that for people not treated before, 14-day bismuth quadruple therapy is the preferred regimen when antibiotic susceptibility is unknown, with rifabutin triple therapy or potassium-competitive acid blocker dual therapy for 14 days as a suitable alternative in patients without penicillin allergy; for people treated before, it states that salvage regimens containing clarithromycin or levofloxacin should only be used if antibiotic susceptibility is confirmed (Chey 2024).

Lion's Mane may have a role as adjunct during and after H. pylori eradication: supporting gastric mucosal healing during the inflammatory recovery period, supporting microbiome restoration after antibiotic disruption, and providing ongoing low-level immune support. This adjunct role is a proposal drawn from the animal and laboratory findings above.

For chronic atrophic gastritis, a long-lasting inflammation of the stomach lining, a 2025 commentary in the World Journal of Gastroenterology states that initial clinical data suggest Lion's Mane may bring clinical and histological (tissue) improvement in patients, along with a marked antimicrobial activity against H. pylori; the authors add that further evidence is needed before proposing it as a complementary approach (Pellegrino 2025).

For chronic gastritis not associated with H. pylori (autoimmune atrophic gastritis, nonsteroidal anti-inflammatory drug-induced gastritis, bile reflux gastritis), the same adjunct role is proposed alongside addressing the underlying cause where possible.

Back to Table of Contents

Functional Dyspepsia and Gastroesophageal Reflux Disease

Functional dyspepsia — chronic upper abdominal discomfort, early satiety, post-prandial fullness, or epigastric burning without identifiable structural cause — affects 10-20% of adults and is one of the most common reasons for gastrointestinal (GI) clinic visits. Conventional management is limited: proton pump inhibitors help some patients, prokinetic agents help others, low-dose tricyclic antidepressants help a subset, and many patients do not get full relief from any single intervention.

Lion's Mane fits the traditional Chinese medicine indication for "stomach yin deficiency" almost exactly — the same constellation of chronic indigestion, dull epigastric pain, reduced appetite, and post-prandial fullness that defines modern functional dyspepsia. The traditional preparation (long-simmered Lion's Mane soup) was given specifically for this presentation, and patient anecdotal reports of benefit are common.

Mechanistically, Lion's Mane may benefit functional dyspepsia through:

For gastroesophageal reflux disease (GERD), Lion's Mane is less directly relevant because the primary problem in gastroesophageal reflux disease is failure of the lower esophageal sphincter rather than gastric mucosal pathology. Lion's Mane may have indirect benefit through gastric emptying support and reduced gastric inflammation, but it is not a substitute for the conventional gastroesophageal reflux disease interventions (weight loss, head-of-bed elevation, dietary trigger identification, proton pump inhibitor therapy when indicated).

Back to Table of Contents

The Gut-Brain Axis Bridge to Cognitive and Mood Effects

The most interesting feature of Lion's Mane's gut effects is that they do not stop at the gut. The gut-brain axis — the bidirectional communication network linking gut microbiome, gut epithelium, enteric nervous system, vagus nerve, and central nervous system — is increasingly recognized as a major regulator of mood, cognition, and even neurodegeneration.

Key gut-to-brain communication channels:

  1. Vagal afferent nerves — the vagus nerve carries information from gut to brainstem (nucleus tractus solitarius), where it influences hypothalamic, limbic, and cortical activity. Hericenones acting on enteric neurons can signal centrally via this route even without crossing the blood-brain barrier (BBB) themselves.
  2. Microbiome-produced neurotransmitters — gut bacteria produce serotonin (90% of the body's serotonin is made by enterochromaffin cells in the gut, influenced by microbiome), gamma-aminobutyric acid (GABA), and dopamine. Microbiome modulation by Lion's Mane prebiotic effects influences these production rates.
  3. Short-chain fatty acids — butyrate, propionate, and acetate produced by colonic bacterial fermentation reach the brain, support microglial health, and reduce neuroinflammation.
  4. Inflammatory cytokine modulation — gut barrier integrity prevents systemic lipopolysaccharide translocation and the chronic low-grade systemic inflammation that drives neuroinflammation. Lion's Mane gut effects reduce this systemic inflammatory tone.
  5. Tryptophan metabolism — gut microbiome regulates the kynurenine pathway of tryptophan metabolism, which influences serotonin availability and neuroactive metabolite production.

This is the molecular bridge that links Lion's Mane's gut effects to its cognitive and mood effects. The hericenones acting peripherally on enteric neurons and the polysaccharides modulating the microbiome both feed back to the brain through these gut-brain axis channels, contributing to the central effects on cognition (Mori 2009) and mood (Nagano 2010) even when the direct central penetration of hericenones is limited. Erinacine A from mycelium adds the direct central effect on top of these indirect gut-brain pathways. See the Gut-Brain Axis page for the broader framework.

Back to Table of Contents

Preparation Choice for Gut Applications

For gut indications specifically, the preparation considerations differ slightly from cognitive applications:

Back to Table of Contents

Dose and Pairing with Other Gut Interventions

Amounts and pairings described for gut use:

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Wong JY et al. (2013). Gastroprotective Effects of Lion's Mane Mushroom Hericium erinaceus (Bull.:Fr.) Pers. (Aphyllophoromycetideae) Extract against Ethanol-Induced Ulcer in Rats. Evidence-Based Complementary and Alternative Medicine. — PubMed PMID: 24302966
  2. Wang XY et al. (2018). Gastroprotective activity of polysaccharide from Hericium erinaceus against ethanol-induced gastric mucosal lesion and pylorus ligation-induced gastric ulcer, and its antioxidant activities. Carbohydrate Polymers. — PubMed PMID: 29455967
  3. Wang D et al. (2019). A polysaccharide from cultured mycelium of Hericium erinaceus relieves ulcerative colitis by counteracting oxidative stress and improving mitochondrial function. International Journal of Biological Macromolecules. — PubMed PMID: 30543884
  4. Tursi A et al. (2024). Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The "HERICIUM-UC" Two-Arm Multicentre Retrospective Study. Pharmaceutics. — PubMed PMID: 39339171
  5. Diling C et al. (2017). Immunomodulatory Activities of a Fungal Protein Extracted from Hericium erinaceus through Regulating the Gut Microbiota. Frontiers in Immunology. — PubMed PMID: 28713364
  6. Brown GD, Gordon S (2001). Immune recognition. A new receptor for beta-glucans. Nature. — PubMed PMID: 11544516
  7. Shang X et al. (2013). In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion's Mane mushroom, Hericium erinaceus (higher Basidiomycetes). International Journal of Medicinal Mushrooms. — PubMed PMID: 23557368
  8. Wang G et al. (2019). In Vitro and In Vivo Inhibition of Helicobacter pylori by Ethanolic Extracts of Lion's Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes). International Journal of Medicinal Mushrooms. — PubMed PMID: 30806251
  9. Chey WD et al. (2024). ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American Journal of Gastroenterology. — PubMed PMID: 39626064
  10. Pellegrino R, Gravina AG (2025). Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis. World Journal of Gastroenterology. — PubMed PMID: 40495939
  11. Diling C et al. (2017). Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota. Oncotarget. — PubMed PMID: 29156761
  12. Khan MA et al. (2013). Hericium erinaceus: an edible mushroom with medicinal values. Journal of Complementary & Integrative Medicine. — PubMed PMID: 23735479
  13. Friedman M (2015). Chemistry, nutrition, and health-promoting properties of Hericium erinaceus. Journal of Agricultural and Food Chemistry. — PubMed PMID: 26244378
  14. Cryan JF, Dinan TG (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. — PubMed PMID: 22968153
  15. Marshall BJ, Warren JR (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet. — PubMed PMID: 6145023
  16. Sonnenburg ED, Sonnenburg JL (2014). Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metabolism. — PubMed PMID: 25156449
  17. McDonald D et al. (2018). American Gut: an Open Platform for Citizen Science Microbiome Research. mSystems. — PubMed PMID: 29795809
  18. Wong KH et al. (2007). Activity of Aqueous Extracts of Lion's Mane Mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) on the Neural Cell Line NG108-15. International Journal of Medicinal Mushrooms. — doi:10.1615/intjmedmushr.v9.i1.70
  19. Nakatsugawa M et al. (2003). Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins. Internal Medicine. — PubMed PMID: 14714963
  20. Maes MF, van Baar HM, van Ginkel CJ (1999). Occupational allergic contact dermatitis from the mushroom White Pom Pom (Hericium erinaceum). Contact Dermatitis. — PubMed PMID: 10344494

PubMed Topic Searches

  1. PubMed: Hericium gastric ulcer
  2. PubMed: Hericium and IBD
  3. PubMed: Beta-glucan and Dectin-1
  4. PubMed: Hericium and microbiome
  5. PubMed: Gut-brain axis and mushrooms

Back to Table of Contents

Connections

Back to Table of Contents